Hughes Steven George — SEC Form 4 filings
SEC reporting owner CIK 1747528. 13 Form 4 filings on record with FilingPulse; latest filed 2026-04-22.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2025-01-08 to 2026-04-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 16 legs across 10 filings — 111,936 shares, $4,855,710 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 28.
- Largest priced transaction: sale of 33,983 shares @ $42.74 ($1,452,342) in Avidity Biosciences, Inc., filed 2025-08-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Avidity Biosciences, Inc. (RNAM) | Chief Medical Officer | 12 | — | 16 legs · 111,936 sh · $4,855,710 | 26 |
| Atrium Therapeutics, Inc. (RNA) | Chief Medical Officer | 1 | — | — | 2 |
Form 4 filings — Hughes Steven George
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-22 | 4 | Atrium Therapeutics, Inc. (RNA) | Grant/award (A): 30,000 @ $0 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | Avidity Biosciences, Inc. (RNAM) | Disposition to issuer (D): 115,857 · Disposition to issuer (D): 73,342 (derivative) · Disposition to issuer (D): 74,000 (derivative) · Disposition to issuer (D): 49,333 (derivative) · Disposition to issuer (D): 68,458 (derivative) · Disposition to issuer (D): 50,000 (derivative) | EDGAR |
| 2026-01-23 | 4 | Avidity Biosciences, Inc. (RNA) | Sale (S): 2,017 @ $72.45 · Sale (S): 2,878 @ $72.45 | EDGAR |
| 2026-01-09 | 4 | Avidity Biosciences, Inc. (RNA) | Sale (S): 2,373 @ $72.23 | EDGAR |
| 2025-10-24 | 4 | Avidity Biosciences, Inc. (RNA) | Option exercise (M): 2,209 @ $10.16 · Sale (S): 2,209 @ $47.54 · Option exercise (M): 2,209 (derivative) @ $0 | EDGAR |
| 2025-09-23 | 4 | Avidity Biosciences, Inc. (RNA) | Option exercise (M): 2,208 @ $10.16 · Sale (S): 2,208 @ $40.58 · Option exercise (M): 2,208 (derivative) @ $0 | EDGAR |
| 2025-09-17 | 4 | Avidity Biosciences, Inc. (RNA) | Option exercise (M): 1,542 @ $6.57 · Sale (S): 1,542 @ $45.41 · Option exercise (M): 1,542 (derivative) @ $0 | EDGAR |
| 2025-08-22 | 4 | Avidity Biosciences, Inc. (RNA) | Option exercise (M): 2,208 @ $10.16 · Sale (S): 2,208 @ $46.40 · Option exercise (M): 2,208 (derivative) @ $0 | EDGAR |
| 2025-08-15 | 4 | Avidity Biosciences, Inc. (RNA) | Option exercise (M): 1,542 @ $6.57 · Sale (S): 1,542 @ $46.66 · Option exercise (M): 1,542 (derivative) @ $0 | EDGAR |
| 2025-08-08 | 4 | Avidity Biosciences, Inc. (RNA) | Option exercise (M): 11,283 @ $15.96 · Sale (S): 11,283 @ $42.74 · Option exercise (M): 12,334 @ $6.57 · Sale (S): 12,334 @ $42.74 · Option exercise (M): 6,167 @ $22.47 · Sale (S): 6,167 @ $42.74 · +7 more | EDGAR |
| 2025-03-21 | 4 | Avidity Biosciences, Inc. (RNA) | Sale (S): 9,578 @ $31.06 | EDGAR |
| 2025-01-23 | 4 | Avidity Biosciences, Inc. (RNA) | Sale (S): 1,915 @ $28.60 · Sale (S): 2,032 @ $28.59 | EDGAR |
| 2025-01-08 | 4 | Avidity Biosciences, Inc. (RNA) | Grant/award (A): 25,000 @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1747528 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →